Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.

Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, Aoki Y, Oku Y, Kunieda E.

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):257-63. doi: 10.1016/j.ijrobp.2013.01.006.

PMID:
23570699
2.

Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. doi: 10.1016/j.ijrobp.2011.06.2003.

PMID:
22104360
3.

CyberKnife radiosurgery for stage I lung cancer: results at 36 months.

Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG.

Clin Lung Cancer. 2007 Sep;8(8):488-92.

PMID:
17922973
4.

Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".

Chang JY, Li QQ, Xu QY, Allen PK, Rebueno N, Gomez DR, Balter P, Komaki R, Mehran R, Swisher SG, Roth JA.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1120-8. doi: 10.1016/j.ijrobp.2014.01.022.

PMID:
24661665
5.

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

Dunlap NE, Larner JM, Read PW, Kozower BD, Lau CL, Sheng K, Jones DR.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):583-9. doi: 10.1016/j.jtcvs.2010.01.046.

6.

Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.

Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e291-7. doi: 10.1016/j.ijrobp.2011.03.052.

PMID:
21640503
7.

Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.

Ricardi U, Frezza G, Filippi AR, Badellino S, Levis M, Navarria P, Salvi F, Marcenaro M, Trovò M, Guarneri A, Corvò R, Scorsetti M.

Lung Cancer. 2014 Jun;84(3):248-53. doi: 10.1016/j.lungcan.2014.02.015.

PMID:
24681279
8.

Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.

Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, Le QT, Loo BW Jr, Diehn M.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):231-7. doi: 10.1016/j.ijrobp.2011.10.071.

PMID:
22381907
9.

Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.

Thibault I, Poon I, Yeung L, Erler D, Kim A, Keller B, Lochray F, Jain S, Soliman H, Cheung P.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):713-9. doi: 10.1016/j.clon.2014.06.018.

PMID:
25085765
10.

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer.

Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Mehran RJ, Roth JA, Swisher SG.

Radiat Oncol. 2012 Sep 10;7:152.

11.

Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.

Li Q, Swanick CW, Allen PK, Gomez DR, Welsh JW, Liao Z, Balter PA, Chang JY.

Radiother Oncol. 2014 Aug;112(2):256-61. doi: 10.1016/j.radonc.2014.07.010.

PMID:
25108807
12.

Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8. doi: 10.1016/j.ijrobp.2009.07.1751.

PMID:
20638194
13.
14.

Stereotactic body radiation therapy in octogenarians with stage I lung cancer.

Sandhu AP, Lau SK, Rahn D, Nath SK, Kim D, Song WY, Gulaya S, Fuster MM, Bazhenova L, Mundt AJ.

Clin Lung Cancer. 2014 Mar;15(2):131-5. doi: 10.1016/j.cllc.2013.08.007.

PMID:
24157245
15.

Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.

Hiraoka M, Matsuo Y, Nagata Y.

Cancer Radiother. 2007 Jan-Feb;11(1-2):32-5.

PMID:
17158081
16.

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.

Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1146-50. doi: 10.1016/j.ijrobp.2009.06.017.

PMID:
19800181
17.

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.

Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):677-82. doi: 10.1016/j.ijrobp.2008.11.042.

PMID:
19251380
18.

Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.

Duncker-Rohr V, Nestle U, Momm F, Prokic V, Heinemann F, Mix M, Reusch J, Messmer MB, Marschner N, Waller CF, Weber WA, Grosu AL.

Strahlenther Onkol. 2013 Jan;189(1):33-40. doi: 10.1007/s00066-012-0224-y.

PMID:
23179248
19.

The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.

Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, Cho BC.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1064-70. doi: 10.1016/j.ijrobp.2013.08.020.

PMID:
24210082
20.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664

Supplemental Content

Support Center